FULGENT GENETIC Cash Flow - Quarterly (NASDAQ:FLGT)

Add to My Stocks
$4.56 $0.11 (2.47%) FLGT stock closing price Jun 18, 2018 (Closing)

For analyzing any company like FULGENT GENETIC from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows FULGENT GENETIC profits, the balance sheet shows FULGENT GENETIC debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. FULGENT GENETIC had cash and cash equivalents of $7.89M at beginning of the quarter and $5.27M at quarter end of 2018 Q1. FULGENT GENETIC cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. The cash from operating activities for FULGENT GENETIC is $ 2018 Q1, which saw a decrease from previous quarter.

View and download details of FULGENT GENETIC cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-1.91M-2.51M-0.88M---5.34M-6.16M-5.05M-0.54M-8.31M
Depreciation Depletion Amortization Cash-Flow-2.09M1.54M1.01M-1.23M----
Net Increase (Decrease) in Assets Liabilities-0.46M-0.71M--0.24M-0.53M-1.85M-1.34M-0.03M-0.33M-1.74M
Cash From (used in) Discontinued Operations------0.07M-0.07M-0.07M-0.07M-
Other Adjustments Net-2.45M1.83M1.09M-10.44M9.98M7.07M1.62M8.18M
Net Cash from (used by) Operating Activities
-1.29M1.33M2.57M2.07M-4.4M3.15M2.35M--0.96M
Increase (Decrease) in Prop Plant And Equipment-1.11M-5.35M-4.21M-1.51M-0.09M-3.77M-3.37M-0.56M-0.17M-2.03M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments1.16M3.3M3.92M3.79M-1.78M-39.01M----
Other Cash Inflow (Outflow) from Investment Activities----------0.17M
Net Cash from (used by) Investment Activities
--2.04M-0.28M2.28M-1.87M-42.79M-3.37M-0.56M-0.17M-2.2M
Issuance (Purchase) of Equity Shares-----24.81M10.59M15.18M-3.5M
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities--0.8M-0.8M-0.8M-20.97M-2.66M-1.41M--
Net Cash from (used by) Financing Activities
--0.77M-0.77M-0.77M-45.78M7.93M13.77M-3.5M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-1.21M-1.4M1.58M3.57M-1.16M7.39M7.7M15.56M--
Cash & Equivalents at Beginning of Year7.89M--1.34M------
Cash & Equivalents at Year End5.27M6.49M9.47M11.47M6.73M7.89M8.2M16.06M1.19M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

FULGENT GENETIC stock comparison chart provides an easy way to compare the stock price with peers along with details of FULGENT GENETIC stock price history.
The statement of cash flows can be categorized into the following main sections:

  • FULGENT GENETIC has cash of $5.27M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the FULGENT GENETIC stock price.
  • FULGENT GENETIC decreased its cash from operating activities to $-1.29M till 2018 Q1. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for FLGT stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for FULGENT GENETIC.

Key Financial Ratios For FULGENT GENETIC Cash Flow